Technology

A pioneering research and development company, Emergence Quantum, has been launched by a University of Sydney team of quantum physicists with a long-standing collaboration with Microsoft Quantum. 

According to a recent study by Oxford Economics, midsized companies in the industrial manufacturing sector are setting their eyes on ambitious growth targets. The research, authored in partnership with SAP, revealed that 38% of industry leaders have identified market expansion as their top priority.

Engineers from Monash University have developed a new type of water-based flow battery that could help Australian households store rooftop solar energy more safely, efficiently, and affordably than current lithium-ion systems.

Researchers at the University of Sydney have performed a quantum simulation of chemical dynamics using real molecules for the first time, marking a major breakthrough in applying quantum computing to chemistry and medicine.

CSL Behring’s state-of-the-art plasma processing facility in Broadmeadows, Victoria, has been awarded the 2025 Facility of the Year in the Pharma 4.0 category by the International Society for Pharmaceutical Engineering (ISPE).

Linde Engineering has signed an agreement with PsiQuantum to supply a large cryogenic cooling plant for what is set to become the world’s first utility-scale quantum computer, to be built in Brisbane, Queensland.

A team of student engineers from Monash University has developed a new autonomous robot that could reshape the way food and goods are delivered in Australia, featuring what is believed to be a world-first innovation in temperature-controlled robotic delivery.

Titomic Limited has entered into a strategic collaboration agreement with DNV, a global assurance and risk management company, to advance the certification of its cold spray additive manufacturing technology for applications in the maritime and oil and gas industries.

A glaring blind spot sits at the heart of most construction projects, one that threatens our ambitions to protect the climate.

A $1.25 million investment is advancing the development of a potential new treatment for advanced and therapy-resistant prostate cancer, with researchers at The University of Queensland moving the drug candidate closer to clinical trials.